𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remission induction in acute myeloid leukemia

✍ Scribed by Eytan M. Stein, Martin S. Tallman

Book ID
120955139
Publisher
Carden Jennings Publishing
Year
2012
Tongue
English
Weight
418 KB
Volume
96
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vincristine (NSC-67574), cytosine arabin
Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): A pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults
✍ Sartiano, George P. ;Pfrimmer, Wayne J. ;Turner, A. Robert πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 412 KB

Fifteen newly diagnosed unselected adult patients with acute nonlymphocytic leukemia were treated in a pilot study of the combination of vincristine, cytosine arabinoside, 6-thioguanine, and daunorubicin (VAT-D) for remission induction therapy. Eleven of fifteen (75%) achieved a remission bone marro

Impact of remission induction chemothera
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization